Amwell® unveiled its next-generation Converge™ telehealth platform at its annual Client Forum. Born out of the profound shift in telehealth usage during the COVID 19 pandemic, from transactional to longitudinal care, this flexible and scalable platform is designed to provide deeper connectivity between healthcare players with unmatched simplicity, reliability, and scalability. With the Converge platform, Amwell’s products, programs, modules and Carepoint™ devices, as well as applications from leading innovators, will be available in one place with a single code base, further enhancing Amwell’s seamless and unified care experience and strengthening existing patient provider relationships across all types of care. The platform’s open architecture is designed to host and operate applications from innovators – further enabling rapid progress towards digitally enabled healthcare. By embracing a diverse group of developers as part of the platform, clients are able to pick and choose the capabilities that matter most to them. Examples include: Google Cloud: Leveraging AI and natural language processing technologies powered by Google Cloud, real-time captioning and translation services will advance provider choices for patient education by surfacing related health education materials based on a patient’s visit. AI-powered tools will engage patients and their care teams before, during and after visits to drive better health insights and outcomes. TytoCare: Livestream integration enables improved diagnosis and treatment for virtual visits using the award-winning TytoCare handheld exam kit featuring built-in visual guidance technology. The Clinic: Providers can request virtual second opinion services for patients, connecting them to one of 3,500 Cleveland Clinic physicians in over 550 advanced sub-specialties via the Amwell platform. Biobeat: Offering a wearable, wireless remote patient monitoring device in two forms: a wrist-monitor for long-term use and a disposable chest-monitor for short-term use, Biobeat provides a tool for the continuous monitoring of 15 vital signs including: blood pressure, heart rate, blood oxygenation and respiratory rate. Biobeat devices are used by healthcare organizations and pharma companies globally; a Biobeat app would enable providers to receive alerts on patient health status and potential deterioration via an AI-powered, automated real-time early warning score system.